Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Net Income (Quarterly): -2.256M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.256M |
| December 31, 2023 | -2.474M |
| September 30, 2023 | -1.820M |
| June 30, 2023 | -2.337M |
| March 31, 2023 | -2.688M |
| December 31, 2022 | -1.766M |
| September 30, 2022 | -2.128M |
| June 30, 2022 | -1.637M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.942M |
| December 31, 2021 | 2.453M |
| September 30, 2021 | -0.8534M |
| June 30, 2021 | -1.556M |
| March 31, 2021 | -2.250M |
| December 31, 2020 | -1.296M |
| September 30, 2020 | -0.4141M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-2.942M
Minimum
Mar 2022
2.453M
Maximum
Dec 2021
-1.598M
Average
-1.820M
Median
Sep 2023
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -4.162M |
| Mirum Pharmaceuticals Inc | -25.28M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -8.211M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.347M |
| EPS Diluted (Quarterly) | -0.19 |
| Enterprise Value | -4.171M |
| Earnings Yield | -1.98K% |